A new study found artificial intelligence-based diagnostics could help with better diagnoses for upper gastrointestinal cancers.
Laparoscopy-assisted distal gastrectomy offered better short-term, post-surgical outcomes for patients with locally advanced gastric cancer who were undergoing neoadjuvant chemotherapy.
Clinicians discuss appropriate evaluation and choice of management strategies for cholangiocarcinoma.
Previous laboratory research along with phase I and II trials suggested the combination of doxorubicin and sorafenib could offer improved outcomes in advanced hepatocellular cancer.
An imaging-based biomarker may offer a way to personalize treatment for pancreatic ductal adenocarcinoma.
The U.S. Preventive Services Task Force released a new review of the benefits and harms of imaging-based screening for pancreatic cancer.
A combination of durvalumab and tremelimumab was tested on patients with metastatic pancreatic ductal adenocarcinoma.
Patients responded relatively well to the phase I trial testing a new treatment for several malignancies, including gastric and gastroesophageal junction adenocarcinomas.
A new study found an upward trend over the last 12 years of cases of gastrointestinal cancer in young patients in Latin America.
Dr. Wilson discusses a chemopreventive drug that may help prevent gastric cancer by acting directly on H. pylori.